Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Monthly Archives: August 2008

Duragesic and Fentanyl Photos

Posted in Duragesic / Fentanyl

I’ve put together a small album with pictures of Fentanyl patches and Duragesic patches.  If you have any other photos of Fentanyl or Duragesic, please email them to me at justinian AT justinian DOT us.  Here are the Fentanyl pictures. 

More Fentanyl patches recalled – not Duragesic this time

Posted in Duragesic / Fentanyl, Recalls

Watson Pharmaceuticals has announced a recall of all 75mcg Fentanyl patches from lot number 92461850.  These patches are being recalled for the same reason many of Johnson & Johnson’s Duragesic patches were recalled: Manufacturing defects that could lead to leakage.  Here’s an excerpt from Watson’s press release: CORONA, CA – August 8, 2008 – Watson… Continue Reading

Company attempting to treat brain tumors with Gadolinium

Posted in Misc. Drugs

I’m excited to see that a company has a promising treatment for brain tumors, but I’m worried that they’re using Gadolinium since that drug can cause Nephrogenic Systemic Fibrosis  (NSF) in people with renal problems: "Enrollment in two Phase 2 trials with motexafin gadolinium for adult brain tumors and childhood gliomas also continues under sponsorship… Continue Reading

Digitek – Worse than Enron?

Posted in Misc. Drugs

I came across an interview with a woman whose partner likely died from defective Digitek, and the following passage jumped out at me: Then I found out that the drug maker knew and did nothing about it. That is beyond words. When I spoke to Jackie’s doctor we both agreed that something should be done… Continue Reading

FDA Approves New Gadolinium Dye

Posted in Uncategorized

The FDA recently approved the Gadolinium dye EOVIST to be used to help detect liver problems.  This makes EOVIST somewhat unique because it’s approved to target problems with specific organs.  Like all Gadolinium dyes, this one also carries an FDA black box warning: “Gadolinium-based contrast agents increase the risk of Nephrogenic Systemic Fibrosis in patients… Continue Reading

Gadolinium (MRI & MRA Contrast Dye)

Posted in Misc. Drugs

SAFETY ALERT: PATIENTS AT RISK OF CONTRACTING RARE DISEASE AFTER RECEIVING MRI OR MRA When a patient undergoes an MRI or an MRA scan, a contrast dye is often used to make the patient’s blood vessels more visible to the doctors.  A commonly used contrast agent is Gadolinium.  Gadolinium is a rare-earth element that has… Continue Reading

Family waited too long to file Duragesic lawsuit, so they automatically lost

Posted in Duragesic / Fentanyl

This case illustrates how important it is to act quickly if you’re considering filing a lawsuit over Duragesic, or any defective drug.  On June 21st of 2008, a federal court decided the case of Schmelzle v. Alza Corp.  (Alza manufactures Duragesic (Fentanyl) patches.)  Kelly Sue Schmelzle died on December 12th of 2003 after using a… Continue Reading

Mylan Pharmaceuticals sued in West Virginia over their “drug in adhesive” Fentanyl patch

Posted in Duragesic / Fentanyl

James Pope was prescribed 50mcg Fentanyl patches on July 23rd of 2007, and died just six days later of a Fentanyl overdose.  This lawsuit is a little different than other Fentanyl lawsuits, as it doesn’t involve the recalled Duragesic or recalled Fentantyl patches.  As far as I know, Mylan has not issued a recall notice… Continue Reading

Duragesic / Fentanyl patients should stay away from grapefruit, heat

Posted in Duragesic / Fentanyl, Safety Alerts

In February, the FDA approved changes to the warning label for the Duragesic (Fentanyl) pain patch, including adding warning patients using the patch not to drink grapefruit juice or expose the patch to a direct heat source. Dose increases should be approached with caution, and patients should avoid grapefruit or grapefruit juice… (Emphasis added.) …. Continue Reading